Corona Virus

Johnson & Johnson seeks FDA authorization of Covid booster shot

J&J said Monday that giving a second dose two months after the first increased protection against symptomatic moderate to severe Covid-19 to 94 percent, with 100 percent protection against severe illness.Read More

Click to comment

Leave a Reply

Your email address will not be published. Required fields are marked *

Most Popular

To Top